EDAP TMS gains CE mark for device to treat prostate cancer

06/20/2013 | MedGadget.com

EDAP TMS has earned the CE mark in Europe for its Focal•One robotic High-Intensity Focused Ultrasound device, which is used to treat prostate cancer patients in a noninvasive manner. The device combines MRI with real-time ultrasound imaging to target tumors better during therapy, among other features.

View Full Article in:

MedGadget.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Medical Director - Cataract
Abbott
Santa Ana, CA